BioNTech SE (BNTX) Total Current Liabilities (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Total Current Liabilities data on file, last reported at $2.5 billion in Q4 2025.

• In Q4 2025, Total Current Liabilities fell 7.51% year-over-year to $2.5 billion; the TTM figure through Dec 2025 stood at $2.5 billion (down 7.51% YoY), while the FY2025 annual figure was $2.4 billion, down 10.23% from the prior year.
• Total Current Liabilities retreated to $2.5 billion in Q4 2025, from $2.6 billion in the prior quarter.
• Across five years, Total Current Liabilities topped out at $5.8 billion in Q3 2021 and bottomed at $1.6 billion in Q1 2021.
• A 5-year average of $2.9 billion and a median of $2.6 billion in 2025 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2021 — Total Current Liabilities surged 1743.58% — and 2023, when it plunged 61.52%.
• Year by year, Total Current Liabilities stood at $4.0 billion in 2021, then declined by 24.42% to $3.0 billion in 2022, then retreated by 26.0% to $2.2 billion in 2023, then rose by 21.03% to $2.7 billion in 2024, then decreased by 7.51% to $2.5 billion in 2025.
• The last three Total Current Liabilities figures came in at $2.5 billion (Q4 2025), $2.6 billion (Q3 2025), and $2.1 billion (Q2 2025), per Business Quant data.

Peer Comparison